Cambridge Healthtech Institute

Cambridge Healthtech Institute

Cambridge Healthtech Institute (CHI) is a leading life science conference and intelligence organization that connects researchers and business professionals from top pharmaceutical, biotech, and academic organizations. CHI produces large-scale conferences, targeted topic forums, newsletters, and industry reports covering areas such as drug discovery, genomics, proteomics, and laboratory informatics.

Claims from Cambridge Healthtech Institute

Cambridge Healthtech Institute
Cambridge Healthtech Institute"Insilico sketched out a timeline that included first patient enrolled by September 2025, last patient enrolled by November 2028, with initial results expected by December 2029, a potential NDA by March 2030 and approval by September 2030."Sep 23, 2026
© 2026 Improve the News Foundation. All rights reserved.Version 8.0.0

© 2026 Improve the News Foundation.

All rights reserved.

Version 8.0.0